triamcinolone acetonide has been researched along with indocyanine green in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 25 (48.08) | 29.6817 |
2010's | 26 (50.00) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Fujisawa, S; Matsubara, M; Tokuda, K; Tsukamoto, T | 1 |
Dunbar, MT; Hunter, MA; Rosenfeld, PJ | 1 |
Choi, JS; Ikuno, Y; Ohji, M; Sakaguchi, H; Tano, T | 1 |
Kroll, P; Meyer, CH; Rodrigues, EB | 1 |
Arf Karacorlu, S; Karacorlu, M; Ozdemir, H | 1 |
Gomi, F; Sakaguchi, H; Sakimoto, S; Tano, Y | 1 |
Arevalo, JF; Garcia, RA; Mendoza, AJ | 1 |
Arevalo, JF; Fernández, CF; Mendoza, AJ | 1 |
Bardak, Y; Cekiç, O; Tiğ, SU | 1 |
Fukushima, M; Hirata, A; Inumaru, J; Koga, T; Mawatari, Y; Tanihara, H | 1 |
Binder, S; Krebs, I; Stolba, U | 1 |
Coupland, SG; Kertes, PJ | 1 |
Eandi, CM; Freund, KB; Goldberg, DE; Klais, CM; Ober, MD; Sorenson, JA; Yannuzzi, LA | 1 |
Bergamini, F; Bottoni, F; Massacesi, A; Romano, M | 1 |
Cameron, JD; Conston, SR; Feng, X; Folden, DV; Olsen, TW; Sierra, DH; Smith, ME; Wabner, K | 1 |
Belting, C; Cresti, F; Genovesi-Ebert, F; Rizzo, S | 1 |
Kak, R; Sandhu, SS; Talks, SJ; van de Moere, A | 1 |
Arevalo, JF; Berrocal, MH; Garcia, RA; Garcia-Amaris, R; Novoa, LA; Rodríguez, A; Rodriguez, FJ; Sanchez, JG; Wu, L | 1 |
Inoue, Y; Iriyama, A; Obata, R; Takahashi, H; Tamaki, Y; Yanagi, Y | 1 |
Baba, T; Fukuda, K; Nomoto, H; Ohtsuki, H; Shiraga, F; Takasu, I; Yamaji, H | 1 |
Ishikawa, K; Ito, Y; Kondo, M; Nishihara, H; Ozawa, S; Piao, CH; Terasaki, H | 1 |
Hattori, T; Mizutani, Y; Mori, R; Nakashizuka, H; Shimada, H; Yuzawa, M | 1 |
Asami, T; Ishikawa, K; Ito, Y; Kachi, S; Sugita, J; Terasaki, H; Yamakoshi, T | 1 |
Farah, ME; Maia, M; Rodrigues, EB | 1 |
Hirano, Y; Nozaki, M; Ogura, Y; Usui, Y; Yasukawa, T | 1 |
Flynn, HW; Gregori, G; Lujan, B; Oh, J; Smiddy, WE | 1 |
Hatta, Y; Ishikawa, K; Ito, Y; Nishihara, H; Ozawa, S; Terasaki, H | 1 |
Iida, T; Kano, M; Saito, M; Shiraga, F; Shiragami, C | 1 |
Arndt, C; Hamel, C; Hattenbach, LO; Martinenq, C; Meunier, I; Rebollo, O | 1 |
Baklouti, K; Bouraoui, R; Chebil, A; el Matri, L; Kort, F; Mghaieth, F | 1 |
Kishi, S; Matsumoto, H; Mukai, R; Sato, T; Watanabe, G | 1 |
Baillif-Gostoli, S; Mauget-Faÿsse, M; Quaranta-El Maftouhi, M | 1 |
Acar, N; Bidot, S; Bretillon, L; Bron, A; Creuzot-Garcher, C; Passemard, M | 1 |
Aaberg, TM; Bergstrom, C; Payne, JF; Srivastava, SK; Yan, J | 1 |
Hirakata, A; Hiraoka, T; Inoue, M; Itoh, Y; Rii, T | 1 |
Barañano, DE; Bergstrom, CS; Cribbs, BE; Fortun, JA; Hubbard, GB; Ray, R; Schwent, BJ; Srivastava, SK | 1 |
Ejstrup, R; Heegaard, S; Kiilgaard, JF; la Cour, M | 1 |
Bandello, F; Giatsidis, S; Introini, U; Scotti, F; Setaccioli, M; Torres Gimeno, A | 1 |
Fujiwara, A; Nitta, E; Shiraga, F; Shiragami, C; Shirakata, Y; Yamashita, A | 1 |
Bryan, JS; De Souza, SA; Gordon, AJ; Heller, MA; Sell, CH; Tsipursky, MS; Ziemianski, MC | 1 |
Abed, E; Falsini, B; Fasciani, R; Mastrocola, A; Montrone, L; Sasso, P; Scupola, A | 1 |
Iida, T; Itagaki, K; Kano, M; Saito, M | 1 |
Kurosaka, D; Machida, S; Murai, K; Nishimura, T; Ohzeki, T; Toba, Y | 1 |
Dar, S; Ehlers, JP; McNutt, S; Srivastava, SK; Tao, YK | 1 |
Chen, KJ; Chen, TL; Chen, YP; Chuang, LH; Hwang, YS; Lai, CC; Wang, NK; Wu, WC; Yeung, L | 1 |
Hayashi, T; Kohno, H; Ohkuma, Y; Sakai, T; Tsuneoka, H; Watanabe, A | 1 |
Enaida, H; Ishibashi, T; Mochizuki, N; Yamamoto, T; Yamashita, H | 1 |
Cheng, L; Gu, B; Li, X; Liu, J; Ma, Q; Shen, M | 1 |
Kurosaka, D; Machida, S; Murai, KI; Nishimura, T; Ohzeki, T | 1 |
Ali, MH; Goerlitz-Jessen, M; Grewal, DS | 1 |
Abroug, N; Ben Amor, H; Khairallah, M; Khochtali, S; Nabi, W | 1 |
1 review(s) available for triamcinolone acetonide and indocyanine green
Article | Year |
---|---|
Dyes in ocular surgery: principles for use in chromovitrectomy.
Topics: Benzenesulfonates; Coloring Agents; Epiretinal Membrane; Humans; Indocyanine Green; Macular Edema; Retinal Perforations; Rosaniline Dyes; Staining and Labeling; Triamcinolone Acetonide; Trypan Blue; Vitrectomy; Vitreoretinopathy, Proliferative | 2009 |
7 trial(s) available for triamcinolone acetonide and indocyanine green
Article | Year |
---|---|
Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Lasers; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: a pilot study.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Embolization, Therapeutic; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Light Coagulation; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2006 |
The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study.
Topics: Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Pilot Projects; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2005 |
Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.
Topics: Aged; Basement Membrane; Coloring Agents; Electroretinography; Female; Glucocorticoids; Humans; Indocyanine Green; Male; Middle Aged; Nerve Fibers; Phacoemulsification; Retinal Cone Photoreceptor Cells; Retinal Ganglion Cells; Retinal Perforations; Rosaniline Dyes; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Visual Fields; Vitrectomy | 2014 |
Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Comparisons of focal macular electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.
Topics: Basement Membrane; Coloring Agents; Electroretinography; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Indicators and Reagents; Indocyanine Green; Intraoperative Period; Macula Lutea; Male; Middle Aged; Retinal Ganglion Cells; Retinal Perforations; Retrospective Studies; Rosaniline Dyes; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy | 2017 |
44 other study(ies) available for triamcinolone acetonide and indocyanine green
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Evaluation of toxicity due to vital stains in isolated rat retinas.
Topics: Animals; Bicarbonates; Coloring Agents; Drug Combinations; Glutathione; Indocyanine Green; L-Lactate Dehydrogenase; Male; Ophthalmic Solutions; Rats; Rats, Sprague-Dawley; Retina; Staining and Labeling; Triamcinolone Acetonide; Trypan Blue | 2004 |
Retinal angiomatous proliferation: clinical characteristics and treatment options.
Topics: Aged; Aged, 80 and over; Angiomatosis; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Photochemotherapy; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide | 2004 |
Multiple components of epiretinal tissues detected by triamcinolone and indocyanine green in macular hole and retinal detachment as a result of high myopia.
Topics: Aged; Coloring Agents; Epiretinal Membrane; Female; Glucocorticoids; Humans; Indocyanine Green; Microscopy, Electron, Transmission; Myopia; Retinal Detachment; Retinal Perforations; Triamcinolone Acetonide; Vitrectomy | 2004 |
Chromovitrectomy: a new field in vitreoretinal surgery.
Topics: Basement Membrane; Coloring Agents; Eye Diseases; Humans; Indocyanine Green; Retinal Diseases; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2005 |
Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery?
Topics: Basement Membrane; Case-Control Studies; Female; Glucocorticoids; Humans; Indocyanine Green; Male; Middle Aged; Retina; Retinal Perforations; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2005 |
Recurrent retinal angiomatous proliferation after surgical ablation.
Topics: Aged; Aged, 80 and over; Angiomatosis; Coloring Agents; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Ophthalmologic Surgical Procedures; Recurrence; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide | 2005 |
The effect of subtenon triamcinolone acetonide injection for diabetic macular edema on retinal and choroidal circulation.
Topics: Blood Circulation; Blood Flow Velocity; Choroid; Connective Tissue; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Regional Blood Flow; Retinal Vessels; Triamcinolone Acetonide | 2005 |
A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiomatosis; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Recurrence; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2006 |
Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy.
Topics: Aged; Aged, 80 and over; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Regional Blood Flow; Retinal Neovascularization; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body | 2006 |
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.
Topics: Animals; Catheterization; Choroid; Coloring Agents; Drug Delivery Systems; Extracellular Space; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Macaca mulatta; Ophthalmoscopy; Retinal Vessels; Swine; Triamcinolone Acetonide; Video Recording | 2006 |
Sutureless 25-gauge vitrectomy for idiopathic macular hole repair.
Topics: Aged; Aged, 80 and over; Basement Membrane; Coloring Agents; Feasibility Studies; Female; Humans; Indocyanine Green; Intraoperative Complications; Male; Microsurgery; Middle Aged; Postoperative Complications; Retinal Perforations; Suture Techniques; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2007 |
Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone.
Topics: Aged; Aged, 80 and over; Angiomatosis; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2007 |
Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Middle Aged; Photochemotherapy; Pilot Projects; Retinal Diseases; Telangiectasis; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Porphyrins; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2008 |
Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results.
Topics: Adult; Aged; Basement Membrane; Coloring Agents; Combined Modality Therapy; Female; Glucocorticoids; Humans; Indocyanine Green; Injections; Male; Middle Aged; Retinal Perforations; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin | 2009 |
Double staining with brilliant blue G and double peeling for epiretinal membranes.
Topics: Aged; Aged, 80 and over; Basement Membrane; Coloring Agents; Epiretinal Membrane; Female; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Recurrence; Rosaniline Dyes; Staining and Labeling; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2009 |
Triamcinolone-assisted removal of internal limiting membrane enhances the effect of vitrectomy for diabetic macular edema.
Topics: Aged; Anti-Inflammatory Agents; Coloring Agents; Diabetes Complications; Female; Humans; Indocyanine Green; Macular Edema; Male; Middle Aged; Retina; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2009 |
Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections, Intraocular; Laser Coagulation; Macula Lutea; Male; Middle Aged; Radiology, Interventional; Retinal Diseases; Telangiectasis; Triamcinolone Acetonide; Visual Acuity | 2010 |
Photoreceptor inner/outer segment defect imaging by spectral domain OCT and visual prognosis after macular hole surgery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorocarbons; Humans; Indocyanine Green; Male; Middle Aged; Photoreceptor Cells, Vertebrate; Prognosis; Prone Position; Retinal Perforations; Retrospective Studies; Sulfur Hexafluoride; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2010 |
Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiomatosis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Male; Middle Aged; Photochemotherapy; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Electrophysiological retinal pigment epithelium changes observed with indocyanine green, trypan blue and triamcinolone.
Topics: Animals; Cattle; Coloring Agents; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Electrophysiology; Glucocorticoids; Indocyanine Green; Membrane Potentials; Retinal Pigment Epithelium; Triamcinolone Acetonide; Trypan Blue | 2010 |
Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Prognosis; Prospective Studies; Retinal Detachment; Retinal Pigment Epithelium; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arterial Occlusive Diseases; Bevacizumab; Choroid; Choroid Diseases; Coloring Agents; Drug Therapy, Combination; Fascia; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Male; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Prospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2010 |
Polypoidal choroidal vasculopathy in a patient with angioid streaks secondary to pseudoxanthoma elasticum.
Topics: Angioid Streaks; Choroid; Choroid Diseases; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Pseudoxanthoma Elasticum; Retinal Pigment Epithelium; Triamcinolone Acetonide; Visual Acuity | 2010 |
Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina.
Topics: Animals; Coloring Agents; Electroretinography; Female; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Indocyanine Green; Injections; Protein Kinase C; Rats; Rats, Sprague-Dawley; Retina; Rosaniline Dyes; Triamcinolone Acetonide; Trypan Blue; Vitreous Body | 2010 |
Residual triamcinolone acetonide sequestered in the fovea after macular hole repair.
Topics: Coloring Agents; Disease Progression; Epiretinal Membrane; Eyeglasses; Female; Follow-Up Studies; Fovea Centralis; Fundus Oculi; Gases; Glucocorticoids; Humans; Indocyanine Green; Injections, Intraocular; Intraocular Pressure; Male; Middle Aged; Postoperative Period; Retinal Perforations; Staining and Labeling; Tissue Distribution; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2011 |
Significant correlation between visual acuity and recovery of foveal cone microstructures after macular hole surgery.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Male; Microscopy, Acoustic; Middle Aged; Phacoemulsification; Recovery of Function; Retinal Cone Photoreceptor Cells; Retinal Perforations; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2012 |
Intraoperative microscope-mounted spectral domain optical coherence tomography for evaluation of retinal anatomy during macular surgery.
Topics: Basement Membrane; Epiretinal Membrane; Humans; Indocyanine Green; Intraoperative Period; Microscopy; Retina; Retinal Perforations; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreoretinal Surgery | 2011 |
Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study.
Topics: Animals; Apoptosis; Blood-Retinal Barrier; Coloring Agents; Dose-Response Relationship, Drug; Electroretinography; Female; Fluorescein Angiography; Glucocorticoids; Indocyanine Green; Models, Animal; Ophthalmoscopy; Retina; Rosaniline Dyes; Sus scrofa; Triamcinolone Acetonide; Vitrectomy | 2012 |
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ranibizumab; Retinal Detachment; Retinal Neovascularization; Retinal Perforations; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2012 |
One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Intravitreal Injections; Male; Photochemotherapy; Recurrence; Retinal Neovascularization; Retreatment; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
Comparative evaluation of no dye assistance, indocyanine green and triamcinolone acetonide for internal limiting membrane peeling during macular hole surgery.
Topics: Aged; Chemotherapy, Adjuvant; Coloring Agents; Epiretinal Membrane; Female; Glucocorticoids; Humans; Indocyanine Green; Male; Middle Aged; Retinal Perforations; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2013 |
Assessment of retinal function before and after idiopathic macular hole surgery.
Topics: Aged; Basement Membrane; Coloring Agents; Electroretinography; Female; Humans; Indocyanine Green; Male; Middle Aged; Postoperative Period; Preoperative Period; Prospective Studies; Retina; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Visual Field Tests; Vitrectomy | 2013 |
Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2014 |
Visualisation of contrast-enhanced intraoperative optical coherence tomography with indocyanine green.
Topics: Animals; Basement Membrane; Coloring Agents; Contrast Media; Epiretinal Membrane; Humans; Indocyanine Green; Intraoperative Period; Prednisolone; Retrospective Studies; Swine; Tomography, Optical Coherence; Triamcinolone Acetonide | 2014 |
Macular hole repair by vitrectomy and internal limiting membrane peeling in highly myopic eyes.
Topics: Adult; Basement Membrane; Endotamponade; Epiretinal Membrane; Female; Fluorocarbons; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Myopia, Degenerative; Retinal Perforations; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2014 |
Long-term outcomes of 3 surgical adjuvants used for internal limiting membrane peeling in idiopathic macular hole surgery.
Topics: Aged; Basement Membrane; Coloring Agents; Epiretinal Membrane; Female; Follow-Up Studies; Humans; Indicators and Reagents; Indocyanine Green; Male; Middle Aged; Retinal Perforations; Retrospective Studies; Rosaniline Dyes; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2014 |
Real-Time Monitoring of Suprachoroidal Space (SCS) Following SCS Injection Using Ultra-High Resolution Optical Coherence Tomography in Guinea Pig Eyes.
Topics: Animals; Choroid; Disease Models, Animal; Extracellular Space; Guinea Pigs; Indocyanine Green; Injections, Intraocular; Intraocular Pressure; Tomography, Optical Coherence; Triamcinolone Acetonide | 2015 |
Rare Complication of Sclerochoroidal Calcifications.
Topics: Aged; Angiogenesis Inhibitors; Calcinosis; Calcium; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Epiretinal Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Macular Edema; Parathyroid Hormone; Retinal Drusen; Scleral Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Vision Disorders; Visual Fields; Vitamin D | 2019 |
IRVAN syndrome: A retrospective review of 9 cases from Tunisia.
Topics: Aneurysm; Bevacizumab; Fundus Oculi; Humans; Indocyanine Green; Macular Edema; Retinal Vasculitis; Retinitis; Retrospective Studies; Triamcinolone Acetonide; Tunisia | 2022 |